TY - JOUR
T1 - American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
AU - Saslow, Debbie
AU - Solomon, Diane
AU - Lawson, Herschel W.
AU - Killackey, Maureen
AU - Kulasingam, Shalini L.
AU - Cain, Joanna
AU - Garcia, Francisco A.R.
AU - Moriarty, Ann T.
AU - Waxman, Alan G.
AU - Wilbur, David C.
AU - Wentzensen, Nicolas
AU - Downs, Levi S.
AU - Spitzer, Mark
AU - Moscicki, Anna Barbara
AU - Franco, Eduardo L.
AU - Stoler, Mark H.
AU - Schiffman, Mark
AU - Castle, Philip E.
AU - Myers, Evan R.
PY - 2012/4
Y1 - 2012/4
N2 - An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from 6 working groups, and a recent symposium cosponsored by the ACS, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology, which was attended by 25 organizations. The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, follow-up (eg, the management of screen positives and screening intervals for screen negatives) of women after screening, the age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16 and HPV18 infections. Cervical cancer screening has successfully decreased cervical cancer incidence and mortality. The American Cancer Society (ACS) guideline for the early detection of cervical cancer was last reviewed and updated in 2002; for the first time, those recommendations incorporated human papillomavirus (HPV) DNA testing.1 Since that time, numerous studies have been published that support changes to recommended age-appropriate screening as well as the management of abnormal screening results, as summarized in Table 1. Copyright
AB - An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from 6 working groups, and a recent symposium cosponsored by the ACS, the American Society for Colposcopy and Cervical Pathology, and the American Society for Clinical Pathology, which was attended by 25 organizations. The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, follow-up (eg, the management of screen positives and screening intervals for screen negatives) of women after screening, the age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16 and HPV18 infections. Cervical cancer screening has successfully decreased cervical cancer incidence and mortality. The American Cancer Society (ACS) guideline for the early detection of cervical cancer was last reviewed and updated in 2002; for the first time, those recommendations incorporated human papillomavirus (HPV) DNA testing.1 Since that time, numerous studies have been published that support changes to recommended age-appropriate screening as well as the management of abnormal screening results, as summarized in Table 1. Copyright
UR - http://www.scopus.com/inward/record.url?scp=84860564294&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860564294&partnerID=8YFLogxK
U2 - 10.1309/AJCPTGD94EVRSJCG
DO - 10.1309/AJCPTGD94EVRSJCG
M3 - Article
C2 - 22431528
AN - SCOPUS:84860564294
SN - 0002-9173
VL - 137
SP - 516
EP - 542
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 4
ER -
